Gulf Times - AstraZeneca
AstraZeneca's 'vaccine for the world' can be 90% effective

AstraZeneca's 'vaccine for the world' can be 90% effective

AstraZeneca said on Monday its Covid-19 vaccine could be as much as 90% effective, giving the world's fight against the global pandemic a new weapon, cheaper to make, easier to distribute and faster to scale-up than rivals.

AstraZeneca Covid-19 vaccine can be 90% effective, results show

AstraZeneca Covid-19 vaccine can be 90% effective, results show

Britain’s AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, giving the world another important tool to halt the Covid-19 pandemic.

India starts vaccine production January, Russia to make second vaccine next year

India starts vaccine production January, Russia to make second vaccine next year

The head of an Indian company contracted to make AstraZeneca Plc's -19 vaccine said India could get access to it by January, as the country's total infections crossed nine million. Mass production of Russia's second vaccine could begin in 2021.

India's Serum says produced 40 mn doses of AstraZeneca Covid-19 vaccine

India's Serum says produced 40 mn doses of AstraZeneca Covid-19 vaccine

Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential Covid-19 vaccine, and would soon begin making Novavax's rival shot ...

US strikes deal with Lilly for potential Covid-19 antibody drug

US strikes deal with Lilly for potential Covid-19 antibody drug

The US government will pay as much as $1.19 billion to Eli Lilly and Co to secure nearly 1 million doses of its experimental Covid-19 antibody treatment, a drug similar to a treatment that US President Donald Trump received.

Spain to receive 31.6 million doses of AstraZeneca Covid-19 vaccine

Spain to receive 31.6 million doses of AstraZeneca Covid-19 vaccine

Spain would receive 31.6 million doses of the Covid-19 vaccine currently being developed by Britain's pharmaceutical giant AstraZeneca between December and June if it is ready, Health Minister Salvador Illa said on Tuesday.

Kids may not be recommended for Covid-19 vaccination initially, US CDC says

Kids may not be recommended for Covid-19 vaccination initially, US CDC says

The US Centers for Disease Control and Prevention (CDC) said on Wednesday that Covid-19 vaccines may not be initially recommended for children, when they become available.

AstraZeneca's Japanese Covid-19 vaccine trial back up, US still paused

AstraZeneca's Japanese Covid-19 vaccine trial back up, US still paused

Clinical trials of AstraZeneca and Oxford University's experimental Covid-19 vaccine have resumed in Japan, almost a month after being put on hold due to an illness of a British volunteer, while discussions with US authorities continue.

Europe lays ground for fast-tracking Covid-19 vaccine reviews

Europe lays ground for fast-tracking Covid-19 vaccine reviews

The European health regulator has started reviewing data on AstraZeneca and Oxford University's potential Covid-19 vaccine in real time, the first of such moves aimed at speeding up any approval process in the region for a vaccine.

Desperately seeking a Covid-19 vaccine - the race is on

Desperately seeking a Covid-19 vaccine - the race is on

Seven months after the emergence of the worst global health crisis in a century the race is on to find the medical equivalent of the Holy Grail -- a Covid-19 vaccine.

Positive news on AstraZeneca Covid-19 vaccine could come Thursday

Positive news on AstraZeneca Covid-19 vaccine could come Thursday

Positive news on initial trials of the University of Oxford's potential Covid-19 vaccine that has been licensed to AstraZeneca could be announced as soon as Thursday, ITV's political editor Robert Peston said, citing a source.

Brazil signs agreement to produce AstraZeneca's experimental Covid-19 vaccine

Brazil signs agreement to produce AstraZeneca's experimental Covid-19 vaccine

Brazil announced on Saturday that it had signed a $127 million agreement to start producing locally an experimental vaccine developed by AstraZeneca that has shown promise to fight the Covid-19 pandemic.